CDK6 and gastric cancer: CDK6-AS1 may serve as a poor independent prognostic biomarker candidate for gastric cancer, demonstrating a positive correlation with its target gene, CDK6. Moreover, CDK6-AS1 is involved in key oncogenic pathways such as the cell cycle and RNA transcription.